10.08.2013 Views

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>KCE</strong> Reports 113 Volume Outcome 57<br />

RELATION BETWEEN SURGEON VOLUME AND 2-YEAR MORTALITY<br />

RATE<br />

Wh<strong>en</strong> international hospital <strong>volume</strong> thresholds (AHRQ or Leapfrog) are applied on<br />

surgeons, low <strong>volume</strong> surgeons (1-5/year) have 13.5% 3 month mortality rate and a<br />

46.8% 2-year mortality rate while high <strong>volume</strong> (≥ 6/year) surgeons have a 6.4% 3 month<br />

mortality and a 41.3% mortality rate (Table 5.12). Survival curve is pres<strong>en</strong>ted in<br />

Figure 5.7. Perc<strong>en</strong>tage of are also pres<strong>en</strong>ted based on the leapfrog cut off (13/year)<br />

Table 5.12: Oes<strong>op</strong>hageal cancer surgery: mortality per surgeon based on<br />

international <strong>volume</strong> thresholds<br />

International cut<br />

off<br />

AHRQ cut<br />

off<br />

Leapfrog<br />

cut off<br />

Surgeon<br />

<strong>volume</strong><br />

category<br />

Number<br />

surgeons<br />

Number<br />

cases<br />

3-months<br />

mortality<br />

Number<br />

<strong>de</strong>aths<br />

2-year<br />

mortality<br />

% Number<br />

<strong>de</strong>aths<br />

6/year 1-5/year 88 156 21 13.5 73 46.8<br />

≥ 6/year 8 140 9 6.4 58 41.3<br />

13/year 1-12/year 90 170 21 12.4 78 45.9<br />

≥ 13/year 6 126 9 7.1 53 42.1<br />

Figure 5.7: Oes<strong>op</strong>hageal cancer surgery: Survival curve by <strong>volume</strong> of<br />

surgeons (based on AHRQ cut off 6/year<br />

Table 5.13 pres<strong>en</strong>t results using the AHRQ threshold. As shown in Table 5.13, results<br />

of logistic regression (with adjustm<strong>en</strong>t for clustering of pati<strong>en</strong>ts within c<strong>en</strong>tres as<br />

explained in Chapter 3 on page 30 (section 3.6.1.3) suggest that high <strong>volume</strong> surgeons<br />

have a lower 2-year mortality than low <strong>volume</strong> surgeons (without reaching statistical<br />

significance), after adjustm<strong>en</strong>t for pati<strong>en</strong>ts and tumour characteristics: the odds ratio<br />

and 95%CI is 1.30 (0.88, 0.91)<br />

%

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!